LOS ANGELES -- In the PRESTIGE-AF trial, survivors of intracerebral hemorrhage (ICH) had good protection against future ischemic events using direct oral anticoagulants (DOACs) -- though, as feared, ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Trauma comes in many forms, and sometimes, what we need is a tight-knit community of those with whom we can all relate. That ...

Stroke survivors were more likely to have little or no disability after 90 days if a clot was removed from a large brain ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...

More than 100 million people globally have had a stroke, but there are ways to reduce your risk and spot the signs of stroke ...

A new study suggests that a simple blood test could help emergency responders quickly determine whether a stroke is caused by ...

MIND was a prospective, open-label trial that enrolled adults up to 80 years old with moderate-large (20-80 mL) ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

Those with a specific type of previous stroke saw a 30% reduced risk. Reviewed by Dietitian Annie Nguyen, M.A., RD Sodium is ...